Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature

BACKGROUND: Oxaliplatin is a platinum compound used in the treatment of gastrointestinal malignancies, including colorectal cancer. The incidence of hypersensitivity reaction in patients receiving oxaliplatin is approximately 15%, with severe reaction (grade 3 and 4) occurring in 2% of patients. CAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Bautista, Marnelli A, Stevens, W Tait, Chen, Chien-Shing, Curtis, Brian R, Aster, Richard H, Hsueh, Chung-Tsen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859393/
https://www.ncbi.nlm.nih.gov/pubmed/20346128
http://dx.doi.org/10.1186/1756-8722-3-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859393/
https://www.ncbi.nlm.nih.gov/pubmed/20346128
http://dx.doi.org/10.1186/1756-8722-3-12

Ejemplares similares